Scarica l'app Stockscreener
526.23
1.17%
-6.25
Pre-mercato:
505.02
-21.21
-4.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$532.48
Aprire:
$530.57
Volume 24 ore:
1.56M
Relative Volume:
0.69
Capitalizzazione di mercato:
$195.56B
Reddito:
$45.20B
Utile/perdita netta:
$6.87B
Rapporto P/E:
28.93
EPS:
18.1888
Flusso di cassa netto:
$6.75B
1 W Prestazione:
-0.43%
1M Prestazione:
+13.26%
6M Prestazione:
-14.99%
1 anno Prestazione:
+26.88%
Intervallo 1D:
$522.56
$532.55
Intervallo di 1 settimana:
$522.56
$544.45
Portata 52W:
$403.36
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, NTRA, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
526.23 | 195.56B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
201.11 | 142.34B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
563.81 | 44.48B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
262.63 | 37.61B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
130.26 | 36.79B | 7.23B | 1.41B | 1.09B | 4.979 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific Inc. stock falls Monday, underperforms market - MarketWatch
How FBI Rapid DNA Approval Shapes Thermo Fisher Scientific’s (TMO) Long-Term Forensics Strategy - Yahoo Finance
Here’s How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years - Benzinga
Exploring Analyst Estimates for Thermo Fisher (TMO) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Thermo Fisher Scientific (TMO) Q2 2026 Preview: EPS Est. $5.71, Reports July 23 - AlphaStreet
Thermo Fisher stock edges higher as investors weigh Q1 2026 growth and guidance - Ad-hoc-news.de
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - AOL.com
Thermo Fisher stock trades steadily as diagnostics demand supports recent earnings - ad-hoc-news.de
Thermo Fisher stock trades steadily as diagnostics and biopharma demand support earnings trajectory - ad-hoc-news.de
Thermo Fisher Scientific Inc. stock falls Friday, underperforms market - MarketWatch
Thermo Fisher stock trades near record levels as diagnostics and biopharma demand support growth - ad-hoc-news.de
Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Precision Trading with Thermo Fisher Scientific Inc (TMO) Risk Zones - Stock Traders Daily
Fund Update: 148,999 THERMO FISHER SCIENTIFIC (TMO) shares added to Canoe Financial LP portfolio - Quiver Quantitative
Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring - TradingView
Thermo Fisher stock reflects a steady life science growth story - Ad Hoc News
Thermo Fisher Scientific (Ondo Tokenized) price today, TMOON to USD live price, marketcap and chart - CoinDesk
Thermo Fisher Set to Report Q2 Earnings: What's in the Cards? - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
World Syringes for Thermo ScientificMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Intuitive Surgical Pre-Q2 Analysis: Buy, Hold or Sell the Stock Now? - TradingView
The Invitrogen EVOS M7000 Imaging SystemThermo Fisher bets on automated cell imaging - Ad Hoc News
Thermo Fisher Scientific lays off nearly 70 Wisconsin employees - Yahoo Finance
Baird Adjusts Price Target on Thermo Fisher Scientific to $652 From $639, Maintains Outperform Rating - Moomoo
Thermo Fisher Stock Looks Cheap Next to Its Own Forecast. Here’s the Math. - TIKR.com
Thermo Fisher Scientific (TMO) Valuation Insights: DCF Analysis Suggests $478 Per Share - GuruFocus
Thermo Fisher Scientific (TMO) 47th Annual Raymond James Institutional Investor Conference summary - Quartr
Thermo Fisher Scientific (TMO) Q1 2026 earnings summary - Quartr
Thermo Fisher stock holds steady as investors await catalysts - ad-hoc-news.de
Thermo Fisher Looks To Block Former Exec's Move To Fortrea - Law360
symbol__ Stock Quote Price and Forecast - CNN
Thermo Fisher stock holds steady as investors focus on life-science demand - ad-hoc-news.de
Thermo Fisher Scientific (TMO) Announces Consistent Quarterly Di - GuruFocus
Thermo Fisher Scientific Keeps Quarterly Dividend at $0.47 per Share, Payable Oct. 15 to Holders of Record Sept. 15 - Moomoo
Thermo Fisher declares $0.47 quarterly dividend By Investing.com - Investing.com Nigeria
Press Release: Thermo Fisher Scientific Announces Quarterly Dividend - 富途牛牛
Thermo Fisher Scientific to lay off 69 - In Business Madison
Thermo Fisher Q2 Preview: Buy Before The Recovery (NYSE:TMO) - Seeking Alpha
Thermo Fisher Scientific strengthens its life science platform as demand for lab tools stays resilie - AD HOC NEWS
Thermo Fisher Sci. steady after recent updates. Investors focus on healthcare demand - Ad-hoc-news.de
Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market - MarketWatch
Thermo Fisher expands its scientific footprint as investors assess long-term growth - Ad-hoc-news.de
Thermo Fisher Scientific Launches GENESYS G5 UV-Visible Spectrophotometer Series - Food Safety Magazine
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - PR Newswire
Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology - Manufacturing Chemist
Thermo Fisher Scientific (TMO) Q3 2025 earnings summary - Quartr
Thermo Fisher (TMO) Wins FBI Approval For Rapid DNA Tool In Crime Investigations - Yahoo Finance
Thermo Fisher Scientific Announces Quarterly Dividend - AOL.com
Thermo Fisher Scientific Launches New Quality Assurance Software - Clinical Lab Products
Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches - AOL.com
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):